Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 121313
Published online Dec 14, 2026. doi: 10.3748/wjg.121313
Published online Dec 14, 2026. doi: 10.3748/wjg.121313
Figure 3 Distribution of glucagon-like peptide-1 receptor agonist and dipeptidyl peptidase-4 inhibitor subtypes among matched-cohort patients with inadequate bowel preparation.
A: Distribution of glucagon-like peptide-1 receptor agonist subtypes; B: Distribution of dipeptidyl peptidase-4 inhibitor subtypes. DPP-4: Dipeptidyl peptidase-4; GLP-1RAs: Glucagon-like peptide-1 receptor agonists.
- Citation: Park HJ, Oh YE, Chi SA, Kim M, Kim JE, Hong SN, Min BH, Kim YH, Chang DK, Kim TS, Kim ER. Impact of glucagon-like peptide-1 receptor agonists on bowel preparation quality for colonoscopy in type 2 diabetes. World J Gastroenterol 2026; 32(46): 121313
- URL: https://www.wjgnet.com/1007-9327/full/v32/i46/121313.htm
- DOI: https://dx.doi.org/10.3748/wjg.121313